Ninety-six healthy men were randomized into the following three groups : warfarin -LSB- international normalized ratio ( INR ) @-@ @ -RSB- transitioned to rivaroxaban @mg once daily ( od ; group A ) ; warfarin ( INR @-@ @ ) followed by placebo od ( group B ) ; and rivaroxaban alone @mg od ( group C ) for @ days .